Inipharm
Inipharm is a company developing liver disease therapies.
All edits
Inipharm
Liver Disease Therapies
Inipharm is a company developing liver disease therapies.
November 11, 2020
SEATTLE & SAN DIEGO--(BUSINESS WIRE)--Inipharm today announced the close of a $35 million Series A financing round.
The Series A funding will support the advancement of Inipharm's lead program through IND filing and into clinical trials. The company also announced that Brian Daniels, M.D., partner at 5AM Ventures, and Hannah Chang, M.D., Ph.D., managing director at Wu Capital, have joined Inipharm's board of directors.
Inipharm's executive leadership includes Brian Farmer, co-founder and chief executive officer of the company, who also serves as an entrepreneur-in-residence at Frazier Healthcare and was chief business officer and chief financial officer at liver and metabolic disease-focused Cirius Therapeutics, as well as chief business officer of Mavupharma prior to its acquisition by AbbVie.
Inipharm
Liver Disease Therapies
Inipharm is advancing a therapeutic pipeline that addresses severe liver diseases
Inipharm is advancing a therapeutic pipeline that addresses severe liver diseases The company's lead program is focused on small-molecules to target the activity of HSD17B13, a target for multiple severe liver and related diseases.
November 11, 2020
Find more companies like Inipharm
